Skip to main content

Want a detailed portfolio tracker?

Nuvation Bio (NUVB) P/E (2021 - 2026)

Nuvation Bio (NUVB) P/E from Mar 31, 2021 to Jul 21, 2026. The TTM Nuvation Bio (NUVB) P/E is -14.96. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Nuvation Bio (NUVB)

YearP/EChange
2026-14.96+0.68%
2025-14.86+1127.05%
2024-1.21-69.63%
2023-3.99+3.26%
2022-3.86-81.88%
2021-21.32N/A

Comparison Nuvation Bio (NUVB) P/E with competitors

Nuvation Bio (NUVB) P/E is -14.96.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.01%
NBYStablecoin Development Corp0.00-100.03%
ENLVEnlivex Ltd0.07-100.50%
FGENFibroGen Inc0.24-101.60%
CHRSCoherus Biosciences Inc0.85-105.67%
FBIOFortress Biotech Inc0.95-106.34%
ORMPOramed Pharmaceuticals Inc1.50-110.05%
AGENAgenus Inc3.01-120.12%
INVAInnoviva Inc3.15-121.08%
VXRTVaxart Inc3.55-123.73%
CRMDCorMedix Inc3.63-124.25%
CVACCureVac N.V.4.45-129.72%
GLPGGalapagos NV4.86-132.48%
SRPTSarepta Therapeutics Inc4.88-132.63%
ABEOAbeona Therapeutics Inc5.39-136.01%
ABUSArbutus Biopharma Corp5.60-137.40%
ZVRAZevra Therapeutics Inc5.89-139.35%
SPROSpero Therapeutics Inc6.23-141.63%
CGENCompugen Ltd6.31-142.20%
RIGLRigel Pharmaceuticals6.87-145.94%
SLXNSilexion Therapeutics Corp7.30-148.77%
OMEROmeros Corporation9.26-161.89%
AUPHAurinia Pharmaceuticals Inc9.58-164.07%
PLXProtalix BioTherapeutics Inc10.89-172.80%
ACADAcadia Pharmaceuticals Inc11.73-178.40%
TBPHTheravance Biopharma Inc12.26-181.96%
ADMAAdma Biologics Inc12.42-183.01%
HRMYHarmony Biosciences Holdings Inc13.82-192.38%
SABSSAB Biotherapeutics Inc14.14-194.49%
NAGENiagen Bioscience Inc14.82-199.05%
INCYIncyte Corp15.82-205.76%
REGNRegeneron Pharmaceuticals Inc15.86-205.99%
PBYIPuma Biotechnology Inc17.32-215.74%
CPRXCatalyst Pharmaceuticals Inc17.44-216.57%
EXELExelixis Inc17.54-217.23%
TGTXTG Therapeutics Inc18.97-226.78%
MDXGMimedx Group Inc20.55-237.38%
XOMAXOMA Royalty Corp22.87-252.91%
ARGXArgen X SE24.30-262.42%
CTMXCytomX Therapeutics Inc24.82-265.92%
XOMAOXOMA Royalty Corp25.34-269.42%
HALOHalozyme Therapeutics Inc25.62-271.28%
XOMAPXOMA Royalty Corp25.67-271.59%
VRTXVertex Pharmaceuticals Inc27.99-287.13%
RPRXRoyalty Pharma plc - Class A28.69-291.76%
SLNOSoleno Therapeutics Inc29.02-293.96%
ASNDAscendis Pharma A/S30.09-301.11%
LGNDLigand Pharmaceuticals Inc - Class B37.91-353.43%
APLSApellis Pharmaceuticals Inc39.02-360.84%
BMRNBiomarin Pharmaceutical Inc42.21-382.17%
KRYSKrystal Biotech Inc45.34-403.10%
ONCBeiGene Ltd69.54-564.85%
PHARPharming Group N.V.75.03-601.51%
TECHBio-Techne Corp101.96-781.55%
VCELVericel Corp109.92-834.78%
ALNYAlnylam Pharmaceuticals Inc117.96-888.55%
GMABGenmab140.29-1037.78%
TLXTelix Pharmaceuticals Ltd162.15-1183.92%
CORTCorcept Therapeutics Inc212.86-1522.86%